Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR1 | P25024 | 14/20 | 0.51 |
| ▸ | CXCR2 | P25025 | 14/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5658556 | 0.84 | NPC1 (0.52) | CXCR1CXCR2ALDH1A1NPC1RAB9A | |
| SCHEMBL5658045 | 0.82 | CXCR2 (0.59) | CXCR1CXCR2NPC1RAB9AP4HTM | |
| SCHEMBL5661096 | 0.81 | CXCR2 (0.67) | CXCR1CXCR2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5658349 | 0.81 | CXCR2 (0.73) | CXCR1CXCR2ALDH1A1NPC1RAB9A | |
| SCHEMBL5656391 | 0.80 | CXCR1 (0.75) | CXCR1CXCR2ALDH1A1P4HTM | |
| SCHEMBL5659069 | 0.80 | CXCR2 (0.59) | CXCR1CXCR2ALDH1A1NPC1RAB9A | |
| SCHEMBL5660773 | 0.80 | CXCR2 (0.52) | CXCR1CXCR2ALDH1A1P4HTM | |
| SCHEMBL5656795 | 0.78 | CXCR2 (0.76) | CXCR1CXCR2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5662987 | 0.77 | CXCR2 (0.51) | CXCR1CXCR2ALDH1A1NPC1RAB9A | |
| SCHEMBL5659634 | 0.77 | CXCR1 (0.58) | CXCR1CXCR2ALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7176310-B1 | Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents | UCB SA (GB) | 2007-02-13 | — | — | US | disclosed |